Gambro Renal Products, Inc. v. NxStage Medical, Inc. | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Gambro Renal Products, Inc. v. NxStage Medical, Inc.

Sort by

Viewing results 1‒3 of 3

LexUS & Canadian companies
Baxter: own devices
...However, Baxter closed in September on its $4bn acquisition of Swedish renal business Gambro and that should render savings....
March 27, 2014
Mergers & Acquisitions
Baxter revives Gambro takeover ambition
...Gambro has since sold several businesses, making the current bid not comparable. Baxter reported third quarter income of $583m on sales of $3.5bn including $629m from renal products....
November 23, 2012
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
US & Canadian companies
FMC acquires US rival Renal Care Group
...FMC is acquiring Renal Care Group for $3.5bn, or $48 a share, adding to its own 87,000 patients in the US the more than 30,000 of the Tennessee-based group....
May 4, 2005

Previous pagePage 1 of 1Next page